Ignite Creation Date:
2025-12-25 @ 1:15 AM
Ignite Modification Date:
2025-12-27 @ 2:45 AM
Study NCT ID:
NCT01177293
Status:
COMPLETED
Last Update Posted:
2021-01-28
First Post:
2010-03-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bioavailability Study Comparing 10 mg Amlodipine Besylate Orally Disintegrating Tablets (ODT) And 10 mg Amlodipine Besylate Capsules
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
A0531096
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None